Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000833488 | SCV000975252 | benign | not provided | 2018-06-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001544460 | SCV001763509 | benign | Combined oxidative phosphorylation deficiency 32 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000833488 | SCV002407713 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000833488 | SCV005297650 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003965620 | SCV004793709 | benign | MRPS34-related disorder | 2019-11-07 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |